Publications

27 Feb 2017
News

Achieving Universal Coverage Without Turning to a Single Payer

2007
Article

Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation

By: Arthur A. Daemmrich

In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details

Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Health Industry; Health Industry; United States

Find at Harvard

Read Now

29 Jul 2021
News

Medical debt was cut nearly in half in states that expanded Medicaid

May 2014 (Revised March 2017)
Case

Unilever's Lifebuoy in India: Implementing the Sustainability Plan

By: Christopher A. Bartlett

Unilever's new Global Brand VP must not only revitalize Lifebuoy soap's sagging market performance, but simultaneously impact the health of one billion people worldwide. The latter challenge comes from Unilever's new CEO who has introduced the Unilever Sustainable... View Details

Keywords: Multinational Management; Corporate Social Responsibility; Strategy Implementation; Marketing Strategy; Mission And Purpose; Change Management; International Business; Global; Fast-moving Consumer Goods; Soap; Corporate Social Responsibility and Impact; Health Care and Treatment; Environmental Sustainability; Global Strategy; Developing Countries and Economies; Beauty and Cosmetics Industry; Health Industry; India

03 Aug 2022
News

How Will Amazon Approach U.S. Primary Care?

25 Aug 2010
Working Paper Summaries

Managerial Practices That Promote Voice and Taking Charge among Frontline Workers

Keywords: by Julia Rose Adler-Milstein, Sara J. Singer & Michael W. Toffel; Health

Innovating in Healthcare: Creating Breakthrough Services, Products, and Business Models

Innovating in Healthcare offers effective approaches for designing, reworking, and implementing innovative healthcare services, products, and business models. It will help anyone working in healthcare service or product development, from hospitals to... View Details

January 2011 (Revised April 2014)
Case

Uptake of Malaria Rapid Diagnostic Tests

By: Nava Ashraf, Natalie Kindred and Richard Sedlmayr

This case describes barriers to adoption of malaria rapid diagnostic tests in Zambia and highlights the importance of understanding end users in promoting product adoption. Rapid diagnostic tests (RDTs) are simple, easy-to-use tools that provide a relatively reliable,... View Details

Keywords: Developing Countries and Economies; Health Pandemics; Technology; Health Care and Treatment; Policy; Behavior; Prejudice and Bias; Health Industry; Zambia

07 Nov 2014
Working Paper Summaries

Do Experts or Collective Intelligence Write with More Bias? Evidence from Encyclopædia Britannica and Wikipedia

Keywords: by Shane Greenstein & Feng Zhu; Information; Publishing

September 2007
Case

Collaborating to Improve

By: Richard M.J. Bohmer and Ingrid M. Nembhard

Madison Memorial Hospital is deciding between a variety of quality improvement strategies. Highlights quality improvement collaborative—organized programs popularized by the Institute for Healthcare Improvement in which teams from multiple institutions work together to... View Details

Keywords: Health Care and Treatment; Service Delivery; Performance Improvement; Quality; Groups and Teams; Cooperation; Integration; Health Industry

Article

Internal Deadlines, Drug Approvals, and Safety Problems

By: Lauren Cohen, Umit Gurun and Danielle Li

Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly... View Details

Keywords: Health; Economics; Government and Politics; Innovation and Invention; Research; Science; Health Industry; Health Industry; Health Industry

SSRN

Find at Harvard

10 Sep 2014
Blog Post

A Summer Reflection

allowing them to take on some very exciting projects. One HBS intern was on the clinics team, seeking to roll out basic primary care health services in stores- this has been in the news a bit lately as it... View Details

Keywords: Technology; Consumer Products / Retail

20 Jul 2021
News

Americans’ Medical Debts Are Bigger Than Was Known, Totaling $140 Billion

02 Sep 2020
News

How to Launch a New Biosciences Product: Start Small or Dive in?

Amy C. Edmondson

Amy C. Edmondson is the Novartis Professor of Leadership and Management at the Harvard Business School, a chair established to support the study of human interactions that lead to the creation of successful enterprises that contribute to the betterment of... View Details

Keywords: health care; health care; health care; health care

March 2018 (Revised January 2019)
Case

Gilead Mexico

By: Michael Chu and V. Kasturi Rangan

With a breakthrough cure for Hepatitis C listing in the U.S. at $1,000/pill, Gilead must now solve the issue of making it available to patients across the world, much as it did for its blockbuster HIV/AIDS antiretrovirals. For Erik Musalem, the new general manager of... View Details

Keywords: Health Care and Treatment; Price; Strategy; Management; Pharmaceutical Industry; Mexico

Article

The Economic Consequences of Hospital Admissions

By: Carlos Dobkin, Amy Finkelstein, Raymond Kluender and Matthew Notowidigdo

We use an event study approach to examine the economic consequences of hospital admissions for adults in two datasets: survey data from the Health and Retirement Study, and hospitalization data linked to credit reports. For non-elderly adults with health insurance,... View Details

Keywords: Personal Finance; Borrowing and Debt; Insurance; Insolvency and Bankruptcy; Health Care and Treatment

Find at Harvard

Read Now

January 2011 (Revised January 2012)
Supplement

The Case of the Unidentified Healthcare Companies2010 (CW)

By: Richard M.J. Bohmer, Ethan S Bernstein, Margarita Krivitski and Srinidhi Reddy

This case presents financial statements and selected rations for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details

Keywords: Financial Statements; Financial Management; Health Care and Treatment; Health Industry; Health Industry

December 1998 (Revised September 1999)
Case

Novartis: Betting on Life Sciences

By: Ray A. Goldberg, Carin-Isabel Knoop and Srinivas Sunder

The merger of Ciba-Geigy and Sandoz produced genomic-based synergies for health care, agribusiness, and nutritional supplements. How to build on the strength of the individual divisions and provide synergies that would continue Novartis' leadership role is the question... View Details

Keywords: Mergers and Acquisitions; Business Divisions; Health Care and Treatment; Leadership; Product Positioning; Science-Based Business; Corporate Strategy; Pharmaceutical Industry